WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Related articles:
Related suggestion:
Chinese premier chairs meeting to solicit opinions on economic workSenior CPC official attends meeting on planning of Beijing's developmentShen Yueyue Stresses Uniting and Guiding Women to Strive for a New LifeDeath toll rises to 10 following Taiwan's 7.3Shen Meets NorovHuang Addresses Sixth ChinaWomen's Symposium Commemorates 30th Anniversary of ChinaChina Issues Action Plan to Advance Disability PreventionHuang Xiaowei Visits CWU Volunteers for Beijing 2022ACWF Holds a Series of Activities to Promote Good Family Traditions of the Revolutionaries
2.1654s , 6573.5859375 kb
Copyright © 2024 Powered by FDA brings lab tests under federal oversight in bid to improve accuracy and safety ,Worldly Wonders news portal